Arthrosurface received FDA 510(k) clearance to market the BOS’s Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.
BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.
The device is used with Arthrosurface’s existing HemiCAP DF® implants and ToeMotion™ systems, offering immediate rigid fixation in cases with metaphyseal bone loss. It is designed to stabilize the joint while maintaining the length and mechanical axis of the toe.
Arthrosurface received FDA 510(k) clearance to market the BOS's Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.
BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.
The...
Arthrosurface received FDA 510(k) clearance to market the BOS’s Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.
BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.
The device is used with Arthrosurface’s existing HemiCAP DF® implants and ToeMotion™ systems, offering immediate rigid fixation in cases with metaphyseal bone loss. It is designed to stabilize the joint while maintaining the length and mechanical axis of the toe.
Copy to clipboard 
